- Adjuvant treatment options in HER2-positive breast cancer.
- Recent management of metastatic TND breast cancer.
- Best sequence of anti-HER2 therapy for MBC patients.
- Adjuvant hormonal therapy in premenopausal breast cancer patients: what is the standard?
- Implication of TND MBC sub-classification in management options.
- Neo-adjuvant hormonal therapy in postmenopausal breast cancer patients.
- Neo-adjuvant therapy options in HER2 positive breast cancer patients.
- Overcoming resistance to anti-HER2 therapy.
- Best sequence of therapy in Luminal MBC.
- Overcoming resistance of hormonal therapy in MBC setting.
- Management of inflammatory breast cancer.
- Role of liquid biopsy and implication in the treatment.
- Breast cancer micro-environment: a target for therapy.
- Role of local management in MBC.
- Parp inhibitors: present and future.
- Fertility issues in young women with breast cancer.
- Special consideration for management of breast cancer in geriatric patients.

- Special situation in MBC:
o Bone only metastasis.
o Brain only metastasis.
o Breast cancer with pregnancy

- Treatment of BRCA 1/2 mutant breast cancer patients.
- CDK4/6
- Can we get away with less neoadjuvant chemotherapy?
- The immune system – a guide to basic immunology
- Introduction to immunotherapies and clinical data
- Overview of recent progress of immunotherapy in cancer
- Melanoma as a model disease for immunotherapy
- Non-small Lung cancer
- Immunotherapy-changing the future
- Small cell lung cancer
- Bladder cancer: going the distance
- New data in breast cancer
- Inside the debate of breast cancer: to screen or not?
- Breast Cancer Screening protocols for high risk individuals
- Abbreviated MRI screening (new trend saves time and lives)
- Does 3D Tomosynthesis improve breast cancer detection?
- Missed breast Carcinoma: Why and how to avoid?
- Supplementary screening using hand held and automated breast ultrasound
- Adding the Merits of contrast to the Ease of Mammography: Can We Highlight What's Behind Breast Asymmetries?
- Multidisciplinary Breast Cancer tumor boards: an Opportunity for Radiologists to Declare Value and Establish Communications.
- Imaging Evaluation of Breast Symptoms
- Mammography BIRADS lexicon; a common language to communicate in the multidisciplinary breast team
- Role of Ultrasound in the diagnosis and loco regional staging of breast cancer
- MRI from indications to interpretation.
- Post breast cancer surveillance protocols
- Follow-up of patients under neo-adjuvant chemotherapy.
- PET CT in the diagnosis and staging of female pelvic malignancies
- A practical approach to female pelvic malignancies
- Cervical Carcinoma from screening, through diagnosis, to post treatment surveillance
- Ovarian Cancer Screening – Ultrasound; Impact on Ovarian Cancer Mortality
- Management of node positive cervical cancer.
- Proton therapy for carcinoma of uterine cervix
- Image-guided brachytherapy in gynecological cancers: treatment technique and clinical outcomes
- Management of advanced endometrial cancer
- IMRT in gynecological cancer treatment.
- Breath holding technique during radiotherapy of the breast
- Intra operative contact x ray 50 Kev brachytherapy for early breast cancer

- Role of interstitial brachytherapy in the treatment of primary or recurrent breast cancer:
- patient selection and technique considerations.
- Proton therapy for breast cancer treatment.
- Updates in radiosurgical management of brain metastasis of breast origin
- Major Changes in the AJCC 8th Edition Cancer Staging.
- Apocrine Lesions of the Breast.
- Molecular characterization of pleomorphic lobular carcinoma in situ in comparison to high grade ductal carcinoma in situ".
- Pseudoinvasive lesios of the breast.
- interesting and challenging breast pathology cases.
- Diagnostic challenges and pitfall: Cervical intraepithelial Neoplasia.
- Endocervical adenocarcinoma: Silva system and IECC classification.
- Overview of Neoplastic Vulvar Lesions.
- Challenging Pap Smears: Cytology/Histology Correlation.
- Overview Non- neoplastic Vulvar Lesion.
- Endometrial Biopsy Interpretation and Differential Diagnosis.
- Problems in the Diagnosis of Molar Pregnancies.
- Interesting and challenging GYN pathology cases.
- State of the art management options of the most common gynaecological malignancies .
- Treatment individualisation and decision making pathways based on the latest evidence addressing
- the needs for fertility preservation.
- Controversies in the management of ovarian, endometrial and cervical cancers “meet the expert session”
- Optimizing treatment and referral pathways of gynaecological cancer patients in Egypt.
- How to minimize the adverse effects of chemotherapy and radiotherapy.
- Will Biosimilars change the cancer landscape in Egypt.
- From problem to success towards health promotion and chemoprevention
- Nutrition and cancer what you need to know
- CACS: Introduction
- Ghrelin receptor agonists for CACS
- Nutritional support in CACS patients
- Other pharmacological treatment options for CACS
- Mirtazapine for CACS: placebo-controlled randomized clinical trial protocol
- Understandability of the Arabic version of the Functional assessment of anorexia-cachexia therapy
- (FAACT) scale by Egyptian cancer patients
- Infection as critical condition in cancer patient
- Nursing care of oral mucositis
- Improve the safety and quality of care
- Nursing care of neutropenia
- Primary nurse assessment
- Nursing care of patient receiving radiotherapy
- Tumor Lysis Syndrome
- Efficacy of arthropod venoms against cancer
- Biodegradable nano polymer drug carriers for cancer therapy
- Relieving pain postmastectomy: Effect of Nursing Intervention
- Stressors and coping strategies among family caregivers having children with lymphoma
- Improving self-efficacy for optimized cancer patient outcomes-